Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03765567 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Placement of Antibiotic Powder in Wounds During the Emergency Room

Study acronym: POWDER
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 1 month later Jul 2026 → Sep 2027
See other at-risk trials from The University of Texas Health Science Center at San Antonio

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jul 2026 to Sep 2027
    • Study completion pushed from Jul 2027 to Sep 2028
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 2 of 4 entries
  2. Notable Primary completion date: Jun 2025 to Jul 2026
    • Study completion date: Jun 2025 to Jul 2027
    v17
  3. Notable Primary completion date: Jun 2024 to Jun 2025v16
  4. Minor 2 versions Re-verified since Mar 11, 2024, no change to tracked fieldsv14-v15
  5. Notable Primary completion date: Jan 2023 to Jun 2024
    • Study completion date: Jan 2023 to Jun 2025
    v13
Show 11 earlier versionsHide 11 earlier versions
  1. Notable Primary completion date: Jan 2022 to Jan 2023v12
  2. Minor 2 versions Re-verified since Oct 8, 2020, no change to tracked fieldsv10-v11
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2020 to Oct 5, 2020
    • Site details revised at 2 of 2 sites
    v9
  4. Notable Start date: Jun 2020 to Dec 2020v8
  5. Notable Start date: Feb 28, 2020 to Jun 2020v7
  6. Minor Site contacts updated at 1 of 2 sitesv6
  7. Notable Start date: Oct 31, 2019 to Feb 28, 2020v5
  8. Notable Start date: May 31, 2019 to Oct 31, 2019v4
  9. Notable Start date: Feb 28, 2019 to May 31, 2019v3
  10. Minor Study sites: 0 to 2
    • Start date: Jan 2019 to Feb 28, 2019
    • Secondary endpoints: details revised at 4 of 4 entries
    • Collaborators revised (2)
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is the first prospective controlled study to determine whether the topical application of vancomycin powder reduces infection-related complications when applied to open fracture injuries in the acute emergency department setting.
Trial Details
NCT Number NCT03765567
Lead Sponsor The University of Texas Health Science Center at San Antonio
Collaborators: United States Army Institute of Surgical Research, San Antonio Military Medical Center
Conditions
(from sponsor)
Open Fracture
Related terms Fractures, Open, Infections
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov